Publications: Paulo H. Verardi
2022
- Generation of Multiple Arbovirus-like Particles Using a Rapid Recombinant Vaccinia Virus Expression Platform.
Wang Y, Griffiths A, Brackney DE, Verardi PH
Pathogens (Basel, Switzerland) (2022) 11(12): PMC4337530 10.1128/JVI.03432-14 - A surprise landing on the of macrocyclic dibridgehead diorganoarsines: syntheses, structures, and reactivities.
Zarcone SR, Verardi PJ, Bhuvanesh N, Gladysz JA
Chemical communications (Cambridge, England) (2022) 58(62):8694-8697 10.1039/d2cc03235j 2021
- Modeling coronavirus spike protein dynamics: implications for immunogenicity and immune escape.
Kunkel G, Madani M, White SJ, Verardi PH, Tarakanova A
Biophysical journal (2021) 120(24):5592-5618 PMC5199616 10.1101/2020.04.07.023903 - Single dose of a replication-defective vaccinia virus expressing Zika virus-like particles is protective in mice.
Jasperse B, O'Connell CM, Wang Y, Verardi PH
Scientific reports (2021) 11(1):6492 PMC7985303 10.1038/s41598-021-85951-7 2020
- Replication-inducible vaccinia virus vectors with enhanced safety in vivo.
O'Connell CM, Jasperse B, Hagen CJ, Titong A, Verardi PH
PloS one (2020) 15(4):e0230711 PMC7117657 10.1371/journal.pone.0230711 - Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime/GP5-Mosaic rVaccinia (VACV) Vaccine Boost.
Cui J, O'Connell CM, Hagen C, Sawicki K, Smyth JA, Verardi PH, Kruiningen HJV, Garmendia AE
Vaccines (2020) 8(1): PMC7157218 10.3390/vaccines8010106 2019
- Correction: A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNγ responses against several genotype 2 strains.
Cui J, O'Connell CM, Costa A, Pan Y, Smyth JA, Verardi PH, Burgess DJ, Van Kruiningen HJ, Garmendia AE
PloS one (2019) 14(2):e0213091 PMC6386357 10.1371/journal.pone.0213091 - A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNγ responses against several genotype 2 strains.
Cui J, O'Connell CM, Costa A, Pan Y, Smyth JA, Verardi PH, Burgess DJ, Van Kruiningen HJ, Garmendia AE
PloS one (2019) 14(1):e0208801 PMC6354972 10.1371/journal.pone.0208801 2014
- Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
Hagen CJ, Titong A, Sarnoski EA, Verardi PH
Virus Res. (2014) 181:43-52 2013
- IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic.
Verardi PH, Legrand FA, Chan KS, Peng Y, Jones LA, Yilma TD
J. Interferon Cytokine Res. (2013) 34(3):169-78 (PMC3942681) - Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses.
Holechek SA, Denzler KL, Heck MC, Schriewer J, Buller RM, Legrand FA, Verardi PH, Jones LA, Yilma T, Jacobs BL
PLoS ONE (2013) 8(10):e77879 (PMC3798613) - Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics.
Grigg P, Titong A, Jones LA, Yilma TD, Verardi PH
Proc. Natl. Acad. Sci. U.S.A. (2013) 110(38):15407-12 (PMC3780884) - Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes.
Cervantes JL, La Vake CJ, Weinerman B, Luu S, O'Connell C, Verardi PH, Salazar JC
J. Leukoc. Biol. (2013) 94(6):1231-41 (PMC3828603) 2012
- A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
Verardi PH, Titong A, Hagen CJ
Hum Vaccin Immunother (2012) 8(7):961-70 (PMC3495727) 2011
- Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.
Papin JF, Verardi PH, Jones LA, Monge-Navarro F, Brault AC, Holbrook MR, Worthy MN, Freiberg AN, Yilma TD
Proc. Natl. Acad. Sci. U.S.A. (2011) 108(36):14926-31 (PMC3169153) 2010
- Development of safe and efficacious viral vaccines for animals.
Yilma T, Verardi P, Jones L
Crit. Rev. Immunol. (2010) 30(3):223-37 2008
- Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.
Peng Y, Lin FC, Verardi PH, Jones LA, Yilma TD
J. Virol. (2008) 83(4):1592-601 (PMC2643767) - Incorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity.
Lin FC, Peng Y, Jones LA, Verardi PH, Yilma TD
J. Virol. (2008) 83(3):1216-27 (PMC2620918) 2006
- Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro.
Peng Y, Lin FC, Verardi PH, Jones LA, McChesney MB, Yilma TD
J. Virol. (2006) 81(5):2187-95 (PMC1865962) 2005
- Nef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus.
Chan KS, Verardi PH, Legrand FA, Yilma TD
Proc. Natl. Acad. Sci. U.S.A. (2005) 102(24):8734-9 (PMC1142211) - Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.
Legrand FA, Verardi PH, Chan KS, Peng Y, Jones LA, Yilma TD
Proc. Natl. Acad. Sci. U.S.A. (2005) 102(8):2940-5 (PMC548597) 2004
- Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.
Legrand FA, Verardi PH, Jones LA, Chan KS, Peng Y, Yilma TD
J. Virol. (2004) 78(6):2770-9 (PMC353749) 2003
- Inexpensive vaccines and rapid diagnostic kits tailor-made for the global eradication of rinderpest, and technology transfer to Africa and Asia.
Yilma T, Aziz F, Ahmad S, Jones L, Ngotho R, Wamwayi H, Beyene B, Yesus M, Egziabher B, Diop M, Sarr J, Verardi P
Dev Biol (Basel) (2003) 114:99-111 2001
- Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins.
Verardi PH, Aziz FH, Ahmad S, Jones LA, Beyene B, Ngotho RN, Wamwayi HM, Yesus MG, Egziabher BG, Yilma TD
J. Virol. (2001) 76(2):484-91 (PMC136817) 2000
- Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity.
Verardi PH, Jones LA, Aziz FH, Ahmad S, Yilma TD
J. Virol. (2000) 75(1):11-8 (PMC113892)